Increasing Decision Quality for Men With Lower Urinary Tract Symptoms
Increasing Decision Quality in Older Men in Selecting Treatment Options for Lower Urinary Tract Symptoms (LUTS): A Pilot Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
In this study, the investigators show that by upskilling of primary care physicians (PCPs) in SDM and leveraging on a novel pictorial Visual Analogue Uroflowmetry Score (VAUS), they can enhance older men's recognition of LUTS and stimulated discussion with their PCPs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2020
CompletedFirst Submitted
Initial submission to the registry
March 26, 2021
CompletedFirst Posted
Study publicly available on registry
April 20, 2021
CompletedApril 20, 2021
March 1, 2021
8 months
March 26, 2021
April 16, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Quality of the decision on the management of lower urinary tract symptoms from the patients' perspective
The Shared Decision Making-9 (SDMQ9) Questionnaire measures decision quality from the perspective of the patient. Nine individual items in the questionnaire is scored from 0 to 5 on a six-point Likert scale ranging from 0 ("completely disagree") to 5 ("completely agree"). Standard scoring for the full scale is the total score, with values from 0 to 45. Higher scores indicate higher quality decisions.
Through study completion, an average of 6 months
Quality of the decision on the management of lower urinary tract symptoms from the physicians' perspective
The Shared Decision Making-Doctor (SDMQDoc) Questionnaire measures decision quality from the perspective of the physician. Nine individual items in the questionnaire is scored from 0 to 5 on a six-point Likert scale ranging from 0 ("completely disagree") to 5 ("completely agree"). Standard scoring for the full scale is the total score, with values from 0 to 45. Higher scores indicate higher quality decisions.
Through study completion, an average of 6 months
Study Arms (2)
Shared decision making for men with lower urinary tract symptoms
EXPERIMENTALParticipants used the Visual Analogue Uroflowmetry Score so report their symptoms and were attended by Primary Care Physicians trained in shared decision making
No shared decision making for men with lower urinary tract symptoms
ACTIVE COMPARATORParticipants did not use the Visual Analogue Uroflowmetry Score to report their symptoms and received usual care by Primary Care Physicians not trained in shared decision making
Interventions
Physicians in this group were trained in shared decision making
Physicians did not receive training in shared decision making
Eligibility Criteria
You may qualify if:
- men aged 50 years old and older attending the polyclinic for routine follow up of a chronic disease (non-communicable disease)
- have moderate-to-severe LUTS and/or poor quality of life (QOL) as assessed by the validated International Prostate Symptom Score (IPSS) of eight or more and/or its individual QOL score of three or more
- men of any local Asian ethnicity and were willing to provide written consent
- can communicate with their allocated PCP in either of the three main local languages; English, Mandarin or Malay.
You may not qualify if:
- have indwelling catheters
- urinary incontinence requiring diapers
- anuria due to any renal pathology
- gross hematuria
- acute urinary retention
- symptoms consistent with an acute urinary tract infection
- existing treatment of LUTS or other prostate pathology
- visual or hearing impairment which render men incapable of understanding the study procedure and providing informed consent
- men unwilling to discuss their LUTS treatment options with their PCP
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SingHealth Polyclinicslead
- Singapore General Hospitalcollaborator
Study Sites (1)
Haidee Ngu
Singapore, 150167, Singapore
Related Publications (1)
Tiwari R, Ng MY, Neo SH, Mangat R, Ho H. Prospective validation of a novel visual analogue uroflowmetry score (VAUS) in 1000 men with lower urinary tract symptoms (LUTS). World J Urol. 2020 May;38(5):1267-1273. doi: 10.1007/s00345-019-02909-1. Epub 2019 Aug 27.
PMID: 31451932BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Tan Ngiap Chuan, MBBS
Singhealth polyclinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2021
First Posted
April 20, 2021
Study Start
April 15, 2019
Primary Completion
November 30, 2019
Study Completion
March 31, 2020
Last Updated
April 20, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share